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Polychlorinated biphenyls (PCBs) are, together
with DDT (dichlorodiphenyltrichloroethane)
and DDT-related chemicals, the most domi-
nating classes of environmental pollutants
worldwide, with concentrations varying in
wildlife and in humans from different areas of
the globe (Damstra et al. 2002). Although all
PCB congeners, either present in commercial
mixtures or as single chemicals, are lipophilic
substances with low water solubility, only
some of them, even within the same class of
chemicals, have a strong tendency to accumu-
late in higher organisms. This is shown by a
few strongly dominating PCB congeners
retained in, for example, humans (Fängström
et al. 2002; Koopman-Esseboom et al. 1994a),
grey seals (Blomkvist et al. 1992), and polar
bears (Letcher et al. 1996), all acting at top of
the food chain. PCB concentrations are gener-
ally in the low micrograms PCB per gram lipid
range among humans (Koopman-Esseboom
et al. 1994b; Sjödin et al. 2000), but higher
levels are occasionally found in individuals
with a heavy consumption of fatty ﬁsh from
contaminated waters (Sjödin et al. 2000) or
with a pronounced diet based on subsistence
food items (Ayotte et al 1997; Fängström et al.
2002). The levels of PCBs have been shown to
slowly decrease (Norén and Meironyté 2000)
as a result of the legislative measures taken to
prohibit the production of PCBs in the early
1970s, leading to lower environmental releases.
Studies have shown negative effects of
PCBs in animals and humans, especially in
newborn infants (Patandin 1999; Winneke
et al. 2002). Reported effects of background
exposure in infants include reduced birth
weight, less postnatal growth (Patandin et al.
1998; Rylander et al. 1996), neonatal hypo-
tonia (Huisman et al. 1995a, 1995b),
impaired development and impaired immune
response (Weisglas-Kuperus 1998; Weisglas-
Kuperus et al. 1995), and lower thyroid hor-
mone levels (Brouwer et al. 1998, 1999;
Koopman-Esseboom et al. 1994a, 1997;
Osius et al. 1999). With few exceptions (e.g.,
Walkowiak et al. 2001), most negative effects
of background levels of PCBs were primarily
related to antenatal exposure, whereas post-
natal effects from PCBs were related mainly to
accidental exposure of infants to rather high
levels of PCBs and other organohalogen sub-
stances (Kuratsune et al. 1996). It is unknown
whether these effects are caused by the PCBs
themselves or by their metabolites.
Hydroxylated PCBs (OH-PCBs), or poly-
chlorobiphenylols, are major metabolites
of PCBs (Letcher et al. 2000). These metabo-
lites are formed by oxidative metabolism of
PCBs, mediated by the cytochrome P450 enzy-
matic system, that generally involves an arene
oxide intermediate (Jerina and Daly 1974).
OH-PCBs, like most phenolic compounds,
are readily conjugated and excreted, but sev-
eral OH-PCB congeners and some other
halogenated phenolic compounds have been
found to be retained in human and wildlife
blood (Bergman et al. 1994; Fängström et al.
2002; Hovander et al. 2002; Letcher et al.
2000; Sandau et al. 2000). The OH-PCB
concentrations so far reported have been
10–20% of the PCB level in humans but
were found to be higher in, for example,
polar bear blood (Sandau et al. 2000). The
three most abundant OH-PCB congeners
retained in the blood are metabolites of
CB105, CB118, CB138, CB153, and CB187
(Hovander et al. 2002), all known to be
among the most persistent and bioaccumula-
tive PCB congeners.
The toxicologic impact of OH-PCBs is
still not known, but several studies indicate
that these metabolites may have adverse
effects in mammals (Meerts et al. 2002). In
animals, OH-PCBs are transferred across the
placenta (Bjerregaard and Hansen 2000;
Korrick et al. 2000; Sala et al. 2001). It is
not yet known at what rate OH-PCBs are
transferred to the human fetus (Meironyté-
Guvenius et al. 2003). The objective of the
present study was to assess PCB and OH-PCB
levels in mothers and children at birth and to
determine the transplacental transfer of PCBs
and OH-PCBs.
Materials and Methods
Cohort. From September 1998 through
December 2000, pregnant women from
the northern part of the Netherlands were
invited by their midwife or obstetrician to
participate in a study on exposure to PCBs
and OH-PCBs and their potential effects
on the development of the newborn infant.
The mothers had to be of Western European
origin, and Dutch had to be their native
language. To establish an optimal study popu-
lation, pregnancy and delivery had to involve
no serious illness or complications. Only
infants born at term (37–42 weeks of gesta-
tion) without congenital anomalies or diseases
were included. Admission of an infant at a
hospital more than 1 day after birth was
an exclusion criterion. The medical ethics
committee of the University of Groningen
Address correspondence to S.D. Soechitram,
University Hospital Groningen, Department of
Paediatrics, PO Box 30.001, 9700 RB Groningen,
the Netherlands. Telephone: 00-31-50-3612470.
Fax: 00-31-3611704. E-mail: norshan@home.nl
We thank all mothers and children who participated
in this study. We also thank I. Athanassiadis for skill-
ful analytical assistance.
The European Commission, Environment and
Climate Program (grant ENV-CT96-0170) ﬁnancially
supported this research.
The authors declare they have no competing
ﬁnancial interests.
Received 29 April 2003; accepted 13 April 2004.
Fetal Exposure to PCBs and Their Hydroxylated Metabolites in a Dutch Cohort
Shalini Devi Soechitram,1 Maria Athanasiadou,2 Lotta Hovander,2 Åke Bergman,2 and Pieter Jan Jacob Sauer1
1University Hospital Groningen, Department of Paediatrics/Beatrix Children’s Hospital, Groningen, the Netherlands; 2Department of
Environmental Chemistry, Stockholm University, Stockholm, Sweden
Polychlorinated biphenyls (PCBs) are still the most abundant pollutants in wildlife and humans.
Hydroxylated PCB metabolites (OH-PCBs) are known to be formed in humans and wildlife.
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taken from the pregnant women in the
second and/or third trimester of their preg-
nancy. Blood samples of the umbilical
cord were taken directly after delivery. Blood
was collected in a vacuum system EDTA
tube (Ritmeester, Utrecht, the Netherlands)
and centrifuged within 24 hr for 5 min at
4,000 rpm. The plasma was transferred to
separate glass tubes with screw caps with
Teﬂon inlayers and stored at –18°C to –20°C
until analysis. A total of 51 paired maternal
and cord blood plasma samples were analyzed
in the present study. An additional 29 mater-
nal blood samples and 11 cord blood samples
were also analyzed, but these samples were
not paired and are not included in this study.
The 51 samples were analyzed at the analyti-
cal laboratory participating in the study.
Chemicals. Hexane and dichloromethane
were of pesticide grade (Fisons, Leicestershire,
England). Methyl tert-butyl ether (MTBE),
2-propanol, and potassium hydroxide (Eka
Nobel AB, Bohus, Sweden), as well as potas-
sium chloride (Merck, Darmstadt, Germany)
and sulfuric acid (98%; BDH Laboratory
Supplies, Poole, England), were of analytic
quality. Ethanol (99.5%) was purchased from
Kemetyl (Haninge, Sweden). Diazomethane
was synthesized as described by Furniss et al.
(1989). Silica gel (< 0.063 mm; Macherey-
Nagel, Düren, Germany) was activated by
heating it overnight at 280°C and allowed
to cool to room temperature before use. All
glassware was heated at 300°C overnight
before use.
Instruments. Gas chromatography (GC)
was performed on a Varian 3400 GC equipped
with an electron capture detector, a Varian
8200 autosampler, and a split/splitless injector
operated in the splitless mode. The fused silica
capillary column used was a nonpolar column,
CP-SIL 8CB (25 m × 0.15 mm × 0.12 µm),
from Chrompack (EA Middelburg, the
Netherlands). The column oven temperature
was programmed as follows: for analysis of
methylated derivatives of OH-PCBs, 80°C
(2 min), then 50°C/min to 200°C, then
1°C/min to 230C°, then 30°C/min to 330°C
(3 min); for analysis of PCBs, 80°C (1 min),
then 20°C/min to 300°C (10 min). The
injector and detector temperatures were
250°C and 360°C, respectively. Hydrogen
was used as carrier gas, and nitrogen was used
as makeup gas.
For the evaporation of solvents during
cleanup of the samples, we used a centrifugal
concentrator (Genevac SF50 Sales Development
Ltd., Ipswich, England). For the phase separa-
tion during the extraction and lipid removal
with concentrated sulfuric acid using test
tubes, we used a Wifug centrifuge (Wifug
Ltd., Bradford, England).
Analysis. The following PCB congeners
were used as analytical standards: 2,3,3´,4,4´-
pentachlorobiphenyl (CB105), 2,2´,3,4,4´,5´-
hexachlorobiphenyl (CB138), 2,2´,3,4´,5,5´-
hexachlorobiphenyl (CB146), 2,2´,3,3´,4,4´,5-
heptachlorobiphenyl (CB170), 2,2´,3,4,4´,
5,5´-heptachlorobiphenyl (CB180), and
2,2´,3,4´,5,5´,6-heptachlorobiphenyl
(CB187), and they were purchased from
Promochem AB (Ulricehamn, Sweden).
2,2´,4,4´,5,5´-Hexachlorobiphenyl (CB153),
2,3,3´,4,4´,5-hexachlorobiphenyl (CB156),
and 2,2´,3,4,4´,5´,6-heptachlorobiphenyl
(CB183) were synthesized in house (Bergman
et al. 1990; Sundström et al. 1973); 2,3´,
4,4´,5-pentachlorobiphenyl (CB118) and
2,3,3´,4,4´, 5,5´-heptachlorobiphenyl (CB189,
internal standard) were synthesized as described
elsewhere (Sundström et al. 1973). A larger
number of PCB congeners are given here than
are given in “Results.” However, for this study,
the ones mentioned here were all analyzed. The
PCB numbering system as suggested by
Ballschmiter et al. (1993) is applied in the
present study.
The parent PCB compounds and their
OH-PCB metabolites are given in Table 1. The
following methoxylated (MeO-PCB) congeners
were used as authentic reference standards to
quantify the methyl ether derivatives of the
hydroxylated PCBs: 4-methoxy-2,3,3´,4´,
5-pentachlorobiphenyl (4-MeO-CB107),
3-methoxy-2,2´,3´,4,4´,5-hexachlorobiphenyl
(3´-MeO-CB138), 4-methoxy-2,2´,3,4´,5,
5´-hexachlorobiphenyl (4-MeO-CB146),
3-methoxy-2,2´,4,4´,5,5´-hexachlorobiphenyl
(3-MeO-CB153), 4-MeO-2,2´,3,3´,4´,5,5´-
heptachlorobiphenyl (4´-OH-CB172), and
4-methoxy-2,2´,3,4´,5,5´,6-heptachloro-
biphenyl (4-MeO-CB187). 4-Methoxy-
2,3,3´,4´,5,5´,6-heptachlorobiphenyl
(4-MeO-CB193) and 4-hydroxy-2,3,3´,4´,
5,5´,6-heptachlorobiphenyl (4-OH-CB193)
were synthesized in house (Bergman et al.
1995) and applied as internal standards. The
MeO-PCB and OH-PCB congeners are num-
bered according to Letcher et al. (2000). For
this study the following OH-PCBs were meas-
ured: OH-CB107, OH-CB153, OH-CB146,
OH-CB138, OH-CB187, and OH-CB172
(all presented in “Results”).
Extraction and cleanup. The extraction
procedure applied in this study is identical to
the method described by Hovander et al.
(2000). The cleanup procedure that was
required to obtain samples pure enough for
analysis was a combination of sulfuric acid
treatment and silica gel/sulfuric acid column
chromatography separations. Both methods are
described by Hovander et al. (2000). Before
extraction, the samples were spiked with
CB189 (2 ng/sample) and 4-OH-CB193
(1 ng/sample). Sample volumes smaller than
approximately 4 g of plasma were adjusted to
5g   with an aqueous 1% potassium chloride
solution before extraction. For each 10 sam-
ples, a solvent blank was run.
The procedure applied for cleanup may
be summarized as follows: To approximately
5 g plasma spiked with internal standards,
1 mL 6 M hydrochloric acid was added and
mixed well. Thereafter, 2-propanol (6 mL)
was added and mixed well; each sample was
extracted and reextracted with 6 and 3 mL of
hexane:MTBE (1:1), respectively. The phases
(a water phase and an organic phase) were sep-
arated by centrifugation. The organic phase
also underwent a washing step with 4 mL
aqueous 1% potassium chloride before reduc-
tion of the organic solvent. The lipid residue
was determined gravimetrically.
The phenolic compounds were isolated
after the extraction from the plasma by using
potassium hydroxide (0.5 M in 50% ethanol)
and were derivatized to their corresponding
methyl ethers by addition of ethereal diazo-
methane (0.5 mL, 3 hr at 4–8°C) before
cleanup and analysis (Hovander et al. 2000).
Results
In total, 214 pregnant women expressed interest
in participating in this study; 104 of them actu-
ally participated in the study. Of these 104, a
random sample of 51 mother–infant pairs were
included in the study.
Clinical characteristics of the mothers and
infants are given in Table 2. The mean ± SD
maternal age was 31 ± 4 years; mean body
mass index (BMI) was 20 ± 3. Infants were
born after a gestational age of 40 ± 1 weeks
with a birth weight of 3,714 ± 461 g. Fifty-ﬁve
percent of the infants were male.
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Table 1. PCB congeners and their respective OH-PCB
metabolites.
Parent PCB Metabolite
CB105 4-OH-CB107
CB118 4-OH-CB107
CB138 4-OH-CB146
CB138 3´-OH-CB138
CB153 4-OH-CB146
CB153 3-OH-CB153
CB170 4´-OH-CB172
CB180 4´-OH-CB172
CB187 4-OH-CB187
Table 2. Characteristics of the study group (n = 51).
Characteristic Value
Maternal age (years; mean ± SD) 31 ± 4
Weight gain during pregnancy (kg; mean ± SD) 13.3 ± 6
Mother’s BMI (mean ± SD) 20 ± 3
Parity, ﬁrst-born/second- or third-born (%) 33/67
Smoking during pregnancy, yes/no (%) 21/79
Alcohol during pregnancy, yes/no (%) 23/77
Sex of child, male/female (%) 55/45
Gestational age (weeks; mean ± SD) 40 ± 1
Apgar score 1 min [median (range)] 9 (4–10)
Birth weight (g; mean ± SD) 3,714 ± 461The results of all PCB and OH-PCB
measurements are presented in Table 3 [mean
(range)]. The sum PCB (sum of six congeners)
in maternal plasma was 268 (113–619) ng/g
lipid [mean (range)], compared with 345
(78–809) ng/g lipid in cord blood. The sum
OH-PCB (sum of six congeners) in maternal
blood was 54 (14–125) ng/g lipid weight com-
pared with 114 (49–244) ng/g lipid in cord
blood. Expressed per gram fresh weight—
a more suitable way of expressing OH-PCB
values because they are more hydrophilic
than are PCBs—the levels were 0.340 (non-
detectable to 0.622) ng/g fresh weight in
maternal blood compared with 0.180 (non-
detectable to 0.407) ng/g fresh weight in cord
blood. The lipid content of maternal plasma
was considerably higher than that of the fetus,
0.7 versus 0.2 g/100 mg plasma.
The ratios of cord versus maternal plasma
concentrations for PCB and OH-PCB con-
geners, expressed in nanograms per gram lipid as
well as nanograms per gram plasma, are shown
in Figure 1. The sum PCBs have a ratio ± SD of
1.3 ± 0.56 when expressed per gram of lipid.
The sum OH-PCBs have a ratio of 2.2 ± 1.33
when expressed per gram of lipid and a ratio of
0.5 ± 0.23 when expressed per gram of plasma.
Table 4 shows the correlation between the
maternal and cord levels for both the PCBs
and the OH-PCBs. Except for CB118 and
CB156, there was a significant correlation
between the maternal and cord plasma levels.
This indicates a transfer of these compounds
across the placental barrier. Figure 2 shows the
correlation between PCB and OH-PCB levels
between maternal and cord plasma.
The correlations between the parent com-
pound and the resulting OH-PCB for both
maternal plasma and cord plasma are given in
Table 5. There was a significant correlation
between the parent compound and resulting
OH metabolite for all congeners.
Discussion
In this study, we found that OH-PCBs,
metabolites of PCBs, are detectable in plasma
of pregnant women who are exposed to back-
ground levels of PCBs in the Netherlands.
Both the PCB pollutants and their OH-PCB
metabolites are also detectable in cord plasma.
Second, plasma levels of OH-PCBs in umbili-
cal cord plasma are 50% of the levels in the
mothers, indicating a considerable placental
transfer. The placental transfer of OH-PCBs
may be explained from their strong binding
to transthyretin (TTR) and active transport
across the placenta. PCBs, in contrast, are
neutral lipophilic compounds strongly
distributed to lipids and therefore less readily
cross the placenta.
The low ratio in PCBs when expressed
per gram of plasma may be explained by the
fact that a newborn infant consists of 15%
fat, in contrast to 25% fat in adults. In our
study, the lipid content of cord plasma is
about 0.2% lipids compared with 0.7% lipids
in the mother. The PCB body burden of the
infant expressed per gram of body weight
therefore is lower than the body burden of
the mother, although the PCB levels are equal
or slightly higher when expressed per gram
of lipid.
Because of the different transfer mechanism
of OH-PCBs, the infant will have a body bur-
den, expressed per body weight of OH-PCBs,
of 50–70% of their mothers, an intriguing
observation making OH-PCBs possibly more
important from a risk assessment viewpoint
than initially thought.
Our finding that there is a correlation
between the maternal and cord levels of both
PCBs and OH-PCBs further supports the
transplacental transfer of both compounds.
PCBs can reach the fetus only by transpla-
cental transfer. OH-PCBs in the fetus can be
the result of transplacental transfer as well as
Children’s Health | Soechitram et al.
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Table 3. PCB and OH-PCB concentrations in corresponding maternal and cord plasma samples [mean (range); n = 51].
PCB Maternal PCB Cord PCB Maternal OH-PCB Cord OH-PCB
congener lw (ng/g) fw (ng/g) lw (ng/g) fw (ng/g) OH-PCB congener lw (ng/g) fw (ng/g) lw (ng/g) fw (ng/g)
CB118 28 (8–69) 0.188 (0.054–0.452) 56 (9–277) 0.093 (0.013–0.470) 4-OH-CB107 10 (0.8–38) 0.060 (ND–0.183) 14 (4–354) 0.022 (ND–0.048)
CB146 10 (2–29) 0.069 (0.015–0.312) 30 (1–106) 0.050 (0.002–0.154) 3-OH-CB153 5 (1.4–13) 0.035 (ND–0.101) 14 (3–38) 0.021 (ND–0.063)
CB153 101 (43–293) 0.700 (0.248–3.514) 115 (25–252) 0.193 (0.037–0.412) 4-OH-CB146 10 (3–27) 0.063 (ND–0.129) 23 (8–58) 0.036 (ND–0.097)
CB138 73 (32–171) 0.496 (0.183–2.040) 77 (20–213) 0.130 (0.029–0.399) 3´-OH-CB138 7 (1.3–26) 0.045 (ND–0.166) 18 (6–50) 0.028 (ND–0.079)
CB156 12 (4–22) 0.084 (0.028–0.215) 29 (7–96) 0.047 (0.013–0.135) 4-OH-CB187 20 (7–49) 0.022 (ND–0.048) 38 (17–69) 0.061 (ND–0.115)
CB180 44 (15–93) 0.300 (0.090–0.961) 37 (11–88) 0.063 (0.019–0.144) 4´-OH-CB172 2 (0.4–6) 0.015 (ND–0.034) 7 (2–18) 0.011 (ND–0.030)
ΣPCB 268 (113–619) 1.837 (0.645–7.432) 345 (78–809) 0.585 (0.134–1.370) ΣOH-PCB 54 (14–125) 0.340 (ND–0.622) 114 (49–244) 0.180 (ND–0.407)
Lipid (%) 0.7 (0.4–1.2) 0.2 (0.1–0.3) Lipid (%) 0.7 (0.4–1.2) 0.2 (0.1–0.3)
Abbreviations: fw, fresh weight; lw, lipid weight; ND, nondetectable.
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Figure 1. Ratio cord versus maternal plasma expressed (A) per lipid weight and (B) per fresh weight (mean ± SD).
Table 4. Correlation between maternal and cord plasma levels of PCBs.
PCB congener (g lipid) Correlation coefﬁcient OH-PCB congener (g fresh weight) Correlation coefﬁcient
CB118 0.03 4-OH-CB107 0.15
CB146 0.34 3-OH-CB153 0.54
CB153 0.57 4-OH-CB146 0.54
CB138 0.36 3´-OH-CB138 0.57
CB156 0.15 4-OH-CB187 0.55
CB180 0.79 4´-OH-CB172 0.58
Sum 0.43 Sum 0.52hydroxylation by the fetus itself. From our
observational study, no ﬁrm conclusions can
be drawn regarding the source of OH-PCBs in
the fetus. Levels of OH-PCBs were, on aver-
age, approximately 50% of maternal levels. At
the same time, the correlation between parent
PCB and resulting OH-PCB was stronger in
the fetus than in the pregnant mother. The
fetus excretes OH-PCBs to the mother,
whereas the mother excretes OH-PCBs in feces
and/or urine. That the correlation between the
parent compound and the OH congener is
rather weak in the mother can be explained by
differences in kinetics between the PCBs and
OH-PCBs. PCBs have a half-life longer than
that of OH-PCBs.
Levels of PCBs found in this study are
almost equal to levels we have found in the
Netherlands in a comparable group of healthy
pregnant women (Koopman-Esseboom et al.
1994b, 1994c). Plasma levels found in this
study versus levels found 10 years ago are, for
CB118, 0.19 versus 0.16 ng/g plasma; for
CB138, 0.50 versus 0.60 ng/g; for CB153,
0.70 versus 0.91 ng/g; and for CB180, 0.30
versus 0.54 ng/g. Although the samples are
analyzed in different laboratories by different
methods, these results might indicate that
PCB levels in the Netherlands do seem to
have hardly declined in these 10 years. We
cannot compare the OH-PCB levels because
OH-PCB levels have not been measured
before in the Dutch population.
One limitation to this study is the time
difference between the blood taken from
the pregnant mother and cord blood. We
do not believe, however, that this time dif-
ference influenced our results. PCB levels
in the mother are the result of lifelong expo-
sure and do not change during pregnancy
(Koopman-Esseboom et al. 1994a). Most
likely, the conversion of PCB to OH-PCB
does not change during pregnancy. Although
we did not measure the level of OH-PCB at
more times during pregnancy, we expected
the levels of both PCBs and OH-PCBs to
be constant during pregnancy and therefore
accepted the time difference between mater-
nal samples and cord samples, caused by
practical considerations.
The mother–infant pairs included in this
study were a random selection from a larger
cohort of mother–infant pairs. The total
group was included on a voluntary basis in
our study. Although we expected to have a
random sample of mothers in our region, we
cannot exclude some bias in the mothers who
volunteered to enter the study. Mothers
might have had some concerns regarding
these environmental compounds. These could
be mothers who select their food carefully,
but also mothers without such opportunities
for food selection who are therefore con-
cerned. Altogether we believe, however, that
our population is a valid representation of the
population in our region.
Sjödin et al. (2000) measured PCB and
OH-PCB levels in Swedish and Latvian ﬁsher-
men consuming either low or high amounts of
ﬁsh from the Baltic Sea, known to be highly
polluted by contaminants. They found CB153
levels in Swedish fishermen ranging from
226 ng/g lipid in low fish consumers to
534 ng/g lipid in high fish consumers. The
CB153 levels in the pregnant women in our
study were 101 ng/g lipid (range, 43–293).
Sjödin et al. (2000) also measured OH-PCB
levels in their subjects. The 4-OH-CB187
levels ranged from 31 ng/g lipid in low fish
consumers to 176 ng/g lipid in high ﬁsh con-
sumers from Latvia and from 43 to 75 ng/g
lipid in their Swedish counterparts. In the
pregnant women in our study, we found much
lower 4-OH-CB187 levels of 20 ng/g lipid
(range, 6.6–49).
Recently, Sandau et al. (2002) also ana-
lyzed OH-PCBs in umbilical cord plasma of
neonates from coastal populations in Québec.
They measured OH-PCB levels in three dif-
ferent areas. In one area (southern Québec),
individuals were exposed to background levels
of PCBs, and in the other two (Nunavik and
Lower North Shore) they were selected because
of their high ﬁsh consumption. The OH-PCB
concentration range for OH-CB187 was
10–250 pg/g plasma; OH-CB146, 4–507 pg/g
plasma; OH-CB153, 3–74 pg/g plasma;
OH-CB107, 3–168 pg/g plasma; OH-CB138,
3–92 pg/g plasma; and OH-CB172, 1–75 pg/g
plasma (Sandau et al. 2002). The concentra-
tions measured in Québec are higher than those
found in our study. This can be explained by
the level of contamination and the mainly ﬁsh
diet of Québec. Also remarkable is a different
pattern in OH-PCBs between the study in
Québec and our study. This might indicate a
different source of PCBs.
OH-PCBs are considered endocrine dis-
ruptors in animals, with effects on thyroid
hormones, estrogens, and testosterone. Animal
studies have shown a signiﬁcant reduction of
thyroid hormones in the brain after exposure
to OH-PCBs. The reduction in thyroid hor-
mones is related to the binding of OH-PCBs
to TTR, which can be explained by the strong
structural resemblance between OH-PCB and
thyroxine (Brouwer et al. 1998; Ghosh et al.
2000). Some OH-PCBs have > 60% higher
affinity for TTR than does thyroxine itself
(Ghosh et al. 2000; Meerts et al. 2000, 2002).
In humans, thyroid hormones are mainly
bound to thyroxine-binding globulin (TBG)
(Brouwer et al. 1998). Whether the binding of
OH-PCBs to TTR has negative effects in
humans is unknown.
Meerts (2001) observed a signiﬁcant pro-
longation of estrous cycles in the offspring
of pregnant rats exposed to OH-CB107 but
found no effect on their reproductive per-
formance. Also, Meerts (2001) observed an
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Figure 2. Correlation between maternal and cord plasma levels for (A) PCB-153 (expressed per lipid weight) and (B) OH-PCB-153 (expressed per fresh weight).
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Table 5. Correlation between parent compound and hydroxy metabolite in maternal and cord plasma.
Parent PCB OH-PCB metabolite Correlation coefﬁcient Correlation coefﬁcient
congener (g lipid) congener (g fresh weight) in maternal sample in cord sample
CB118 4-OH-CB107 0.21 0.46
CB138 4-OH-CB146 0.38 0.58
CB138 3´-OH-CB138 0.26 0.33
CB153 4-OH-CB146 0.39 0.49
CB153 3-OH-CB153 0.27 0.33
CB180 4´-OH-CB172 0.48 0.45Children’s Health | Soechitram et al.
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impaired habituation in male rat offspring
but not in female offspring.
Whether OH-PCBs do have an effect in
the human on either the thyroid or sex hor-
mones is unknown. TBG and not TTR is the
main transport protein of thyroxine in
humans. TTR, however, might be important
for the transfer of thyroid hormones into the
brain. Further studies in humans are needed
to elucidate if OH-PCBs have a negative effect
on the human fetus or older individuals.
Conclusion
Our study indicates that OH-PCBs can be
found in the plasma of healthy pregnant
women in the Netherlands. The level of OH-
PCBs in cord plasma is approximately 50% of
levels found in the mother. So both PCBs and
OH-PCBs cross the placenta. In both cord
and maternal plasma, OH-PCBs are corre-
lated with the respective parent PCBs. The
only way to reduce the exposure of the fetus to
these potentially toxic compounds is to reduce
the body burden of PCBs in pregnant women.
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